Search Results

Off-Label-Use: Therapiefreiheit des Arztes.

• Authors : Lenke, Beate

Subjects: *DRUG labeling; *PHYSICIANS; *HEALTH insurance companies

• Source: GesR: Gesundheitsrecht. Nov2020, Vol. 19 Issue 11, p707-708. 2p.

Record details

FDA revises package insert.

• Authors : Debris, Janelle¹

Subjects: *DRUG labeling; *MEDICAL care; PHARMACISTSUNITED States

• Source: Pharmacy Today. Feb2007, Vol. 13 Issue 2, p32-33. 2p.

Record details

Applied Science & Technology Full Text (H.W. Wilson)

Record details

Education Full Text (H.W. Wilson)

Record details

Can Patient-Centered Prescription Labels Increase Medication Adherence? Researchers evaluated how changes in USP labeling standards have affected adherence across multiple classes of drugs.

• Authors : Marzella, Meg

Subjects: *DRUG labeling; *MEDICAL care; PATIENT compliance

• Source: Drug Topics. Feb2023, Vol. 167 Issue 2, p25-25. 1p.

Record details

Medications and Acute Hemolysis in G6PD‐Deficient Patients – A Real‐World Study.

• Authors : Gronich, Naomi; Rosh, Bar; Stein, Nili

Subjects: FAVA bean; ANALGESICS; DRUG labeling

• Source: Clinical Pharmacology & Therapeutics; Dec2024, Vol. 116 Issue 6, p1537-1543, 7p

Record details

At Presstime.

Subjects: *DRUG labeling; *MEDICAL care; MEDICAL prescriptionsUNITED StatesUNITED States. Food & Drug Administration

• Source: Managed Care Outlook. 71/2008, Vol. 21 Issue 13, p1-1. 1/3p.

Record details

Applying Pharmacogenomic Guidelines to Combat Medical Care.

• Authors : DeLuca, Jesse (AUTHOR); Oliver, Thomas (AUTHOR); Hulsopple, Chad (AUTHOR)

Subjects: MEDICAL care; INDIVIDUALIZED medicine; DRUG labelingUNITED States

• Source: Military Medicine. 2022 Supplement, Vol. 187, p18-24. 7p.

Record details

News in brief...

Subjects: *PHARMACEUTICAL industry; *DRUG labeling; *AYURVEDIC medicineUNITED States. Food & Drug Administration

• Source: Reactions Weekly. 8/27/2005, Issue 1066, p2-3. 3p.

Record details

Evernorth Will Offer a Private-Label Stelara Biosimilar in 2025.

• Authors : Myshko, Denise

Subjects: COST control; CROHN'S disease; PSORIATIC arthritisUNITED States

• Source: Formulary Watch. 9/6/2024, p1-2. 2p.

Record details